About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNANCT01158066

Association Between Non-alcoholic Fatty Liver Disease (NAFLD) and Coronary Artery Calcification

Coronary artery disease are 8 times more prevalent in patients with NAFLD then the general population and are being considered the most common cause of death. Cardiac CT is a reliable non invasive met...

Lead sponsor: Ziv Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Assy Nimer, MD

CONTACT

+97246828445 assy.n@ziv.health.gov.il

Sponsors

Lead Sponsor

Ziv Hospital

Coronary artery disease are 8 times more prevalent in patients with NAFLD that the general population and are being considered the most common cause of death. Cardiac CT is a reliable non invasive method in demonstrating Coronary Plaques. However the association between coronary artery calcium score (CAC) and NAFLD remains controversial. AIM: the aim is to evaluate the association between CAC score ( CT) and NAFLD (CT). the working hypothesis is that Beside the traditional risk factors including age, diabetes, NAFLD is also associated with moderate to high risk of CAD.

Age

45 - 75 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patients who will undergo cardiac CT for patients with low to intermediate risk for CAD

Exclusion Criteria

•Patients with PCI or CABG will be excluded

Related studies

A Novel Ferumoxytol-enhanced Cardiac Magnetic Resonance for the Detection of Calcified Coronary Arteries

NCT07400406 · Coronary Artery Calcification

RECRUITINGPhase 4

High-intensity Statin and Ezetimibe Therapy for Asymptomatic Patients With Positive Coronary Calcium

NCT05845424 · Coronary Artery Calcification, Metabolic Syndrome, and more

COMPLEX Registry - a Prospective COhort Study to Describe the Management and Outcomes of Patients Presenting with CompLEX and Calcified Coronary Artery Disease

NCT06075602 · Coronary Disease, Coronary Artery Disease, and more

Active Not RecruitingNA

The InterVitaminK Trial - Effects of Vitamin K Supplementation on Cardiovascular, Metabolic, and Bone Health

NCT05259046 · Coronary Artery Calcification, Arterial Stiffness

Active Not RecruitingNA

Quebec Lung Cancer Screening PLUS Trial

NCT05444062 · COPD, Coronary Artery Calcification

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 6, 2011Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment120

Start dateAug 2011

Last updatedApr 6, 2011

Condition

Coronary Artery Calcification

Locations shown

Ziv medical center liver unit

Safed, Israel

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 6, 2011Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions